
The World Health Organization has issued new guidance recommending that children under ten should not receive obesity medications, including GLP-1 weight-loss injections like Mounjaro and Wegovy. Although most of these drugs lack approval for such young patients, some physicians prescribe them outside their licensed indications, and pharmaceutical companies are currently conducting trials on children as young as six. This recommendation reflects growing concern about introducing pharmaceutical interventions early in childhood without sufficient long-term evidence of safety and efficacy.
Kerr University™ subscribers
This lesson continues with 3 more vocabulary words, the full article, natural-voice audio and discussion questions. Subscribers get every Daily News lesson, at every level.
New here? Book a free 30-minute class or try a free sample story.
Open the full interactive lesson with tap-to-hear on every word →